Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Oct 1;34(5):714-720.
doi: 10.1097/WCO.0000000000000963.

Neuromuscular hyperexcitability syndromes

Bram De Wel  1   2 , Kristl G Claeys  1   2
Affiliations
Review

Neuromuscular hyperexcitability syndromes

Bram De Wel et al. Curr Opin Neurol. .

Abstract

Purpose of review: To provide an update on recent developments regarding acquired, antibody-mediated, neuromuscular hyperexcitability syndromes, including Isaac's and Morvan's syndromes, cramp-fasciculation syndrome and rippling muscle disease, and their genetic differential diagnoses.

Recent findings: Antibodies in auto-immune peripheral nerve hyperexcitability syndromes (PNHS) are directed against CASPR2 and LGI1, proteins of the voltage-gated potassium channel (VGKC) complex. We discuss the significance of 'double-negative' VGKC antibodies in PNHS and the rationale for ceasing VGKC antibody testing (but testing CASPR2 and LGI1 antibodies instead) in clinical practice. Recent case reports also expand the possible clinical phenotypes related to CASPR2/LGI1 antibodies, but the interpretation of these findings is complicated by the frequent association of antibody-mediated neuromuscular hyperexcitability syndromes with other auto-immune disorders (e.g. myasthenia gravis).Finally, a hereditary origin of neuromuscular hyperexcitability should always be considered, even in non-VGKC-related genes, as evidenced by the recently discovered high frequency of HINT1 mutations in people of Slavic origin.

Summary: This review provides an update on recent clinical, immunological and genetic developments in neuromuscular hyperexcitability syndromes. We also provide a guide for the clinician for diagnosing and managing these disorders in clinical practice, with a special focus on the main differential diagnoses.

PubMed Disclaimer

References

    1. Kortman HG, Veldink JH, Drost G. Positive muscle phenomena-diagnosis, pathogenesis and associated disorders. Nat Rev Neurol 2012; 8:97–107.
    1. Katirji B. Peripheral nerve hyperexcitability. In: Handbook of Clinical Neurology. Elsevier; 2019; 161:281–290.
    1. Maddison P. Neuromyotonia. Clin Neurophysiol 2006; 117:2118–2127.
    1. Irani SR, Pettingill P, Kleopa KA, et al. Morvan syndrome: clinical and serological observations in 29 cases. Ann Neurol 2012; 72:241–255.
    1. Masood W, Sitammagari KK. Morvan Syndrome (Morvan Fibrillary Chorea, MFC) [Updated 2020 Aug 16]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021.

Substances